Cardiac-specific knockdown of Bhlhe40 attenuates angiotensin II (Ang II)-Induced atrial fibrillation in mice

Atrial fibrosis and atrial inflammation are associated with the pathogenesis of atrial fibrillation (AF). Basic helix–loop–helix family member E40 (Bhlhe40) is an important transcription factor, which is involved in tumors, inflammation, apoptosis, viral infection, and hypoxia. However, its role and molecular mechanism in AF remain unclear. In this study, a mouse model of AF was induced by Ang II infusion. The atrial diameter was evaluated using echocardiography. Induction and duration of AF were measured by programmed electrical stimulation. Atrial structural remodeling was detected using routine histologic examinations. Our results showed that Bhlhe40 was significantly upregulated in angiotensin II (Ang II)-stimulated atrial cardiomyocytes and atrial tissues and in tissues from patients with AF. Cardiac-specific knockdown of Bhlhe40 in mice by a type 9 recombinant adeno-associated virus (rAAV9)-shBhlhe40 significantly ameliorated Ang II-induced atrial dilatation, atrial fibrosis, and atrial inflammation, as well as the inducibility and duration of AF. Mechanistically, cardiac-specific knockdown of Bhlhe40 attenuated Ang II-induced activation of NF-κB/NLRP3, TGF-1β/Smad2 signals, the increased expression of CX43, and the decreased expression of Kv4.3 in the atria. This is the first study to suggest that Bhlhe40 is a novel regulator of AF progression, and identifying Bhlhe40 may be a new therapeutic target for hypertrophic remodeling and heart failure.

[1]  Zhenshun Cheng,et al.  Dec1 Deficiency Ameliorates Pulmonary Fibrosis Through the PI3K/AKT/GSK-3β/β-Catenin Integrated Signaling Pathway , 2022, Frontiers in Pharmacology.

[2]  E. Chan,et al.  BHLHE40 promotes macrophage pro‐inflammatory gene expression and functions , 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  Ming-Yu Yang,et al.  Altered Expression of Circadian Clock Genes in Patients with Atrial Fibrillation Is Associated with Atrial High-Rate Episodes and Left Atrial Remodeling , 2021, Diagnostics.

[4]  M. Mayr,et al.  Paracrine signalling by cardiac calcitonin controls atrial fibrogenesis and arrhythmia , 2020, Nature.

[5]  R. Hunter,et al.  Inflammation and adiposity: new frontiers in atrial fibrillation. , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[6]  M. Makishima,et al.  Dec1 deficiency protects the heart from fibrosis, inflammation, and myocardial cell apoptosis in a mouse model of cardiac hypertrophy. , 2020, Biochemical and biophysical research communications.

[7]  S. Nattel,et al.  Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy , 2020, Circulation research.

[8]  Hui-Hua Li,et al.  The deubiquitinase UCHL1 regulates cardiac hypertrophy by stabilizing epidermal growth factor receptor , 2020, Science Advances.

[9]  P. Ghosh,et al.  Non-circadian aspects of BHLHE40 cellular function in cancer , 2020, Genes & cancer.

[10]  G. Natoli,et al.  A molecular network regulating the pro-inflammatory phenotype of human memory T lymphocytes , 2020, Nature Immunology.

[11]  J. L. Albright.  Critical Analysis , 2020, Management Control Systems and Tools for Internationalization Success.

[12]  Hui-Hua Li,et al.  Inhibition of UCHL1 by LDN-57444 attenuates Ang II–Induced atrial fibrillation in mice , 2019, Hypertension Research.

[13]  Y. Muragaki,et al.  Dec1 Deficiency Suppresses Cardiac Perivascular Fibrosis Induced by Transverse Aortic Constriction , 2019, International journal of molecular sciences.

[14]  D. Dobrev,et al.  Role of inflammatory signaling in atrial fibrillation. , 2019, International journal of cardiology.

[15]  Corey L. Reynolds,et al.  Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation , 2018, Circulation.

[16]  Hui-Hua Li,et al.  Administration of ubiquitin-activating enzyme UBA1 inhibitor PYR-41 attenuates angiotensin II-induced cardiac remodeling in mice. , 2018, Biochemical and biophysical research communications.

[17]  A. Nakashima,et al.  Dec1 and CLOCK Regulate Na+/K+-ATPase &bgr;1 Subunit Expression and Blood Pressure , 2018, Hypertension.

[18]  Chih-Chung Lin,et al.  Bhlhe40 is an essential repressor of IL-10 during Mycobacterium tuberculosis infection , 2018, The Journal of experimental medicine.

[19]  Keji Zhao,et al.  The transcription factor Bhlhe40 is a switch of inflammatory versus antiinflammatory Th1 cell fate determination , 2017, The Journal of experimental medicine.

[20]  F. Akar,et al.  Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes , 2017, Cardiovascular Diabetology.

[21]  S. Nattel,et al.  The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis. , 2016, Cardiovascular research.

[22]  Maxim N. Artyomov,et al.  IL-1–induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation , 2016, The Journal of experimental medicine.

[23]  Klemen Ziberna,et al.  Compromised redox homeostasis, altered nitroso–redox balance, and therapeutic possibilities in atrial fibrillation , 2016, Cardiovascular research.

[24]  Y. Muragaki,et al.  DEC1 and DEC2 Crosstalk between Circadian Rhythm and Tumor Progression , 2016, Journal of Cancer.

[25]  Lihong Chen,et al.  Recent advances in circadian rhythms in cardiovascular system , 2015, Front. Pharmacol..

[26]  Stanley Nattel,et al.  The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. , 2014, Circulation research.

[27]  Nazem Akoum,et al.  Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. , 2014, JAMA.

[28]  Jonathan H. Esensten,et al.  CD28-inducible transcription factor DEC1 is required for efficient autoreactive CD4+ T cell response , 2013, The Journal of experimental medicine.

[29]  Ellen C. Jensen*.  Quantitative Analysis of Histological Staining and Fluorescence Using ImageJ , 2013, Anatomical record.

[30]  Y. Liu,et al.  SUMOylation of DEC1 Protein Regulates Its Transcriptional Activity and Enhances Its Stability , 2011, PloS one.

[31]  J. Haefliger,et al.  An angiotensin II- and NF-kappaB-dependent mechanism increases connexin 43 in murine arteries targeted by renin-dependent hypertension. , 2010, Cardiovascular research.

[32]  T. Lawrence.  The nuclear factor NF-kappaB pathway in inflammation. , 2009, Cold Spring Harbor perspectives in biology.

[33]  Bramahn . Singh,et al.  Atrial fibrillation: from ion channels to bedside treatment options. , 2009, Journal of electrocardiology.

[34]  S. Dudley,et al.  Redox regulation, NF-kappaB, and atrial fibrillation. , 2009, Antioxidants & redox signaling.

[35]  S. Saksena.  New frontiers in atrial fibrillation , 2006 .

[36]  R. Flavell,et al.  Defective T cell activation and autoimmune disorder in Stra13-deficient mice , 2001, Nature Immunology.

[37]  Silvia G. Priori,et al.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC , 2006 .